Vanderbilt University, Vanderbilt University Medical Center Department of Pharmacology, and Vanderbilt Program in Drug Discovery, Nashville, Tennessee, USA.
ACS Chem Neurosci. 2010 Apr 21;1(4):263-4. doi: 10.1021/cn100022a.
On August 14th, 2009, for the first time, the FDA has approved a psychotropic medication for two indications simultaneously. Saphris (asenapine) is a multitarget atypical antipsychotic medication approved to treat adults with schizophrenia and bipolar I disorder.
2009 年 8 月 14 日,FDA 首次同时批准一种精神药物用于两种适应证。Saphris(阿塞那平)是一种多靶标非典型抗精神病药物,获批用于治疗精神分裂症成年患者和双相 I 型障碍患者。